2 3 4 5 6

Financial News

Oct 29, 2018

WACKER's Newly Acquired Pharmaceutical Protein Production SynCo Bio Partners B.V. in the Netherlands is Now Wacker Biotech B.V.

As of November 1, 2018, the pharmaceutical protein production facility in the Netherlands acquired by WACKER with its takeover of SynCo Bio Partners Luxembourg S.à r.l., will be renamed Wacker Biotech B.V.

Oct 25, 2018

After First Nine Months, WACKER Confirms Forecast of Higher Sales and EBITDA for Full-Year 2018

Thanks to the strong performance of its chemical business, Wacker Chemie AG’s sales and EBITDA continued to grow in the second quarter of 2018, both year over year and quarter over quarter.

Sep 12, 2018

WACKER Starts Cystine Production in Spain

WACKER BIOSOLUTIONS, the life sciences division of the WACKER Group, has begun producing fermentation-generated cystine at its new site in León, Spain.

Jul 26, 2018

WACKER’s Sales and Earnings Rise in Q2 2018 Amid Strong Performance in Chemicals

Thanks to the strong performance of its chemical business, Wacker Chemie AG’s sales and EBITDA continued to grow in the second quarter of 2018, both year over year and quarter over quarter.

Jun 12, 2018

WACKER POLYMERS to Raise Prices for Dispersions and Dispersible Polymer Powders

WACKER POLYMERS is raising its prices for vinyl-acetate-ethylene-based copolymer dispersions, dispersible polymer powders and solid resins of its VINNAPAS®, VINNOL®, ETONIS®, VINNACEL® and SMARGO® brands worldwide.

2 3 4 5 6